Boemer, F.; Josse, C.; Luis, G.; Di Valentin, E.; Thiry, J.; Cello, C.; Caberg, J.-H.; Dadoumont, C.; Harvengt, J.; Lumaka, A.;
et al. Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. Int. J. Mol. Sci. 2022, 23, 2253.
https://doi.org/10.3390/ijms23042253
AMA Style
Boemer F, Josse C, Luis G, Di Valentin E, Thiry J, Cello C, Caberg J-H, Dadoumont C, Harvengt J, Lumaka A,
et al. Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. International Journal of Molecular Sciences. 2022; 23(4):2253.
https://doi.org/10.3390/ijms23042253
Chicago/Turabian Style
Boemer, François, Claire Josse, Géraldine Luis, Emmanuel Di Valentin, Jérôme Thiry, Christophe Cello, Jean-Hubert Caberg, Caroline Dadoumont, Julie Harvengt, Aimé Lumaka,
and et al. 2022. "Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy" International Journal of Molecular Sciences 23, no. 4: 2253.
https://doi.org/10.3390/ijms23042253
APA Style
Boemer, F., Josse, C., Luis, G., Di Valentin, E., Thiry, J., Cello, C., Caberg, J.-H., Dadoumont, C., Harvengt, J., Lumaka, A., Bours, V., & Debray, F.-G.
(2022). Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. International Journal of Molecular Sciences, 23(4), 2253.
https://doi.org/10.3390/ijms23042253
